Wanda Chan

3.4k total citations
63 papers, 2.4k citations indexed

About

Wanda Chan is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Wanda Chan has authored 63 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Molecular Biology and 20 papers in Genetics. Recurrent topics in Wanda Chan's work include Growth Hormone and Insulin-like Growth Factors (33 papers), Estrogen and related hormone effects (20 papers) and Bioactive Compounds and Antitumor Agents (11 papers). Wanda Chan is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (33 papers), Estrogen and related hormone effects (20 papers) and Bioactive Compounds and Antitumor Agents (11 papers). Wanda Chan collaborates with scholars based in United States, Canada and Spain. Wanda Chan's co-authors include Bridget Butler, Heng‐Chun Li, Armando Barreto, R. Cheng, A. D. Baines, Roy G. Smith, Gerard J. Hickey, E. Μ. Convey, Matthew J. Wyvratt and William R. Schoen and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Biochemical and Biophysical Research Communications.

In The Last Decade

Wanda Chan

63 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanda Chan United States 27 944 743 642 533 407 63 2.4k
Claus T. Christoffersen Denmark 20 367 0.4× 884 1.2× 429 0.7× 230 0.4× 366 0.9× 47 1.8k
Hiroyuki Odaka Japan 26 822 0.9× 888 1.2× 225 0.4× 202 0.4× 549 1.3× 45 2.3k
Graeme Semple United States 25 468 0.5× 989 1.3× 188 0.3× 386 0.7× 197 0.5× 65 1.9k
Edmund J. Sybertz United States 29 387 0.4× 884 1.2× 734 1.1× 277 0.5× 845 2.1× 93 3.4k
Margaret van Heek United States 21 426 0.5× 527 0.7× 887 1.4× 244 0.5× 684 1.7× 40 2.7k
Kang Cheng United States 26 322 0.3× 881 1.2× 107 0.2× 428 0.8× 254 0.6× 70 1.9k
Douglas S. Compton United Kingdom 17 368 0.4× 519 0.7× 741 1.2× 215 0.4× 498 1.2× 24 2.5k
Scott W. Rowlinson United States 30 454 0.5× 1.3k 1.7× 54 0.1× 742 1.4× 237 0.6× 55 3.7k
Elisabeth Christiansen Denmark 21 533 0.6× 1.0k 1.4× 105 0.2× 153 0.3× 290 0.7× 28 1.6k
Judith L. Treadway United States 32 709 0.8× 1.7k 2.2× 58 0.1× 551 1.0× 455 1.1× 63 2.8k

Countries citing papers authored by Wanda Chan

Since Specialization
Citations

This map shows the geographic impact of Wanda Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanda Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanda Chan more than expected).

Fields of papers citing papers by Wanda Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanda Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanda Chan. The network helps show where Wanda Chan may publish in the future.

Co-authorship network of co-authors of Wanda Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Wanda Chan. A scholar is included among the top collaborators of Wanda Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanda Chan. Wanda Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blizzard, Timothy A., Candido Gude, Wanda Chan, et al.. (2007). Androstene-3,5-dienes as ER-β selective SERMs. Bioorganic & Medicinal Chemistry Letters. 17(22). 6295–6298. 9 indexed citations
2.
Lu, Zhijian, James R. Tata, Kang Cheng, et al.. (2007). Highly potent growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 17(13). 3657–3659. 8 indexed citations
3.
Wilkening, Robert R., Ronald W. Ratcliffe, Dong‐Fang Meng, et al.. (2006). Estrogen receptor β-subtype selective tetrahydrofluorenones: Use of a fused pyrazole as a phenol bioisostere. Bioorganic & Medicinal Chemistry Letters. 16(15). 3896–3901. 29 indexed citations
4.
Blizzard, Timothy A., Wanda Chan, Elizabeth T. Birzin, et al.. (2005). Estrogen receptor ligands. Part 14: Application of novel antagonist side chains to existing platforms. Bioorganic & Medicinal Chemistry Letters. 15(23). 5124–5128. 15 indexed citations
5.
Kim, Seongkon, Jane Y. Wu, Helen Y. Chen, et al.. (2004). Estrogen receptor ligands. Part 4: The SAR of the syn-dihydrobenzoxathiin SERAMs. Bioorganic & Medicinal Chemistry Letters. 14(11). 2741–2745. 23 indexed citations
6.
Chen, Helen Y., Seongkon Kim, Jane Y. Wu, et al.. (2004). Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs. Bioorganic & Medicinal Chemistry Letters. 14(10). 2551–2554. 30 indexed citations
7.
Blizzard, Timothy A., Ralph T. Mosley, Elizabeth T. Birzin, Wanda Chan, & Milton L. Hammond. (2004). Comparison of 2-phenylspiroindenes and 2-phenylspiroindenediones as estrogen receptor ligands—modeling and binding data don't agree!. Bioorganic & Medicinal Chemistry Letters. 14(5). 1317–1321. 4 indexed citations
8.
Liu, Jian, Elizabeth T. Birzin, Wanda Chan, et al.. (2004). Estrogen receptor ligands. Part 11: Synthesis and activity of isochromans and isothiochromans. Bioorganic & Medicinal Chemistry Letters. 15(3). 715–718. 31 indexed citations
9.
Tan, Qiang, Elizabeth T. Birzin, Wanda Chan, et al.. (2004). Estrogen receptor ligands. Part 5: The SAR of dihydrobenzoxathiins containing modified basic side chains. Bioorganic & Medicinal Chemistry Letters. 14(14). 3747–3751. 14 indexed citations
10.
Chen, Helen Y., Kevin D. Dykstra, Elizabeth T. Birzin, et al.. (2004). Estrogen receptor ligands. Part 1: The discovery of flavanoids with subtype selectivity. Bioorganic & Medicinal Chemistry Letters. 14(6). 1417–1421. 42 indexed citations
11.
Peekhaus, Norbert, Marc Ferrer, Oleg Kornienko, et al.. (2003). A β -Lactamase-Dependent Gal4-Estrogen Receptor β Transactivation Assay for the Ultra-High Throughput Screening of Estrogen Receptor β Agonists in a 3,456-Well Format. Assay and Drug Development Technologies. 1(6). 789–800. 26 indexed citations
12.
Lu, Zhijian, James R. Tata, Kang Cheng, et al.. (2003). Substituted bridged phenyl piperidines: orally active growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 13(10). 1817–1820. 5 indexed citations
13.
Ye, Zhixiong, Raman K. Bakshi, Meng‐Hsin Chen, et al.. (2000). Modeling directed design and biological evaluation of quinazolinones as non-peptidic growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 10(1). 5–8. 19 indexed citations
14.
Chen, Meng‐Hsin, Arthur A. Patchett, Kang Cheng, et al.. (1999). Synthesis and biological activities of spiroheterocyclic growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 9(9). 1261–1266. 28 indexed citations
15.
Lin, Peter, Judith M. Pisano, William R. Schoen, et al.. (1999). Acyclic structural variants of growth hormone secretagogue L-692,429. Bioorganic & Medicinal Chemistry Letters. 9(22). 3237–3242. 8 indexed citations
16.
Yang, Lihu, Yanping Pan, Ravi P. Nargund, et al.. (1998). Tripeptide growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 8(7). 759–764. 8 indexed citations
17.
Barakat, Khaled J., Wanda Chan, Thomas M. Jacks, et al.. (1998). Synthesis and biological activities of phenyl piperazine- based peptidomimetic growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 8(11). 1431–1436. 15 indexed citations
18.
Yang, Lihu, Kristine Prendergast, Kang Cheng, et al.. (1998). Potent 3-spiropiperidine growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 8(1). 107–112. 39 indexed citations
19.
Schoen, William R., Judith M. Pisano, Kit Prendergast, et al.. (1994). A Novel 3-Substituted Benzazepinone Growth Hormone Secretagogue (L-692,429). Journal of Medicinal Chemistry. 37(7). 897–906. 85 indexed citations
20.
Chan, Wanda, et al.. (1992). PMA-sensitive protein kinase C is not necessary in TRH-stimulated prolactin release from female rat primary pituitary cells. Life Sciences. 51(25). 1957–1967. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claus T. Christoffersen Breakdown of academic impact, for papers by Hiroyuki Odaka Breakdown of academic impact, for papers by Graeme Semple Breakdown of academic impact, for papers by Edmund J. Sybertz Breakdown of academic impact, for papers by Margaret van Heek Breakdown of academic impact, for papers by Kang Cheng Breakdown of academic impact, for papers by Douglas S. Compton Breakdown of academic impact, for papers by Scott W. Rowlinson Breakdown of academic impact, for papers by Elisabeth Christiansen Breakdown of academic impact, for papers by Judith L. Treadway
Rankless by CCL
2026